American Journal of Respiratory and Critical Care Medicine | 2021
FEV1 Minimum Important Difference versus Minimal Detectable Difference? In Search of the Unicorn
Abstract
1. Schmidt M, Hajage D, Lebreton G, Monsel A, Voiriot G, Levy D, et al.; Groupe de Recherche Clinique en REanimation et Soins intensifs du Patient en Insuffisance Respiratoire aiguE (GRC-RESPIRE) Sorbonne Universit e; Paris-Sorbonne ECMO-COVID investigators. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med 2020;8:1121–1131. 2. Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, et al.; Extracorporeal Life Support Organization. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet 2020;396:1071–1078. 3. COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 2021;47:60–73. 4. Mustafa AK, Alexander PJ, Joshi DJ, Tabachnick DR, Cross CA, Pappas PS, et al. Extracorporeal membrane oxygenation for patients with COVID-19 in severe respiratory failure. JAMA Surg 2020;155:990–992. 5. Stahl K, Seeliger B, Hoeper MM, David S. “Better be awake”-a role for awake extracorporeal membrane oxygenation in acute respiratory distress syndrome due to Pneumocystis pneumonia. Crit Care 2019;23:418. 6. Hoeper MM, Wiesner O, Hadem J, Wahl O, Suhling H, Duesberg C, et al. Extracorporeal membrane oxygenation instead of invasive mechanical ventilation in patients with acute respiratory distress syndrome. Intensive Care Med 2013;39:2056–2057. 7. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al.; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 2021;384:693–704. 8. Mauri T, Turrini C, Eronia N, Grasselli G, Volta CA, Bellani G, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2017;195:1207–1215. 9. Wilkerson RG, Adler JD, Shah NG, Brown R. Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19. Am J Emerg Med 2020;38:2243.e5–2243.e6. 10. Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of ‘happy’ hypoxemia in COVID-19. Respir Res 2020;21:198. 11. Demoule A, Vieillard Baron A, Darmon M, Beurton A, G eri G, Voiriot G, et al. High-flow nasal cannula in critically iii patients with severe COVID19. Am J Respir Crit Care Med 2020;202:1039–1042. 12. Grieco DL, Menga LS, Cesarano M, Ros a T, Spadaro S, Bitondo MM, et al.; COVID-ICU Gemelli Study Group. Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: The HENIVOT randomized clinical trial. JAMA [online ahead of print] 25 Mar 2021; DOI: 10.1001/jama.2021.4682. 13. Vaporidi K, Akoumianaki E, Telias I, Goligher EC, Brochard L, Georgopoulos D. Respiratory drive in critically ill patients. Pathophysiology and clinical implications. Am J Respir Crit Care Med 2020;201:20–32. 14. Crotti S, Bottino N, Ruggeri GM, Spinelli E, Tubiolo D, Lissoni A, et al. Spontaneous Breathing during Extracorporeal Membrane Oxygenation in Acute Respiratory Failure. Anesthesiology 2017;126:678–687. 15. Hermens JA, Braithwaite SA, Platenkamp M, Wijnandts PR, Van de Graaf EA, van der Kaaij NP, et al. Awake ECMO on the move to lung transplantation: serial monitoring of physical condition. Intensive Care Med 2017;43:707–708. 16. Langer T, Santini A, Bottino N, Crotti S, Batchinsky AI, Pesenti A, et al. “Awake” extracorporeal membrane oxygenation (ECMO): pathophysiology, technical considerations, and clinical pioneering. Crit Care 2016;20:150.